Global NewsNews

Vivimed Labs bags approval from Uzbekistan govt

The approvals are for Bilastin tablets, which are used for the treatment of allergic Rhino conjunctivitis and Urticaria

Vivimed Labs has received approval from the Uzbekistan government for two products. The company has received approval for Bilastin tablets, which are used for the treatment of allergic Rhino conjunctivitis and Urticaria, the Hyderabad-based company said in a regulatory filing.

THIS CAN BE YOUR ADVERTISEMENT

Vivimed has also received approval for Orzole combi, which is used to treat gastrointestinal infections such as acute diarrhoea or dysentery, gynaecological, lung and urinary infections, it added.

“The company’s strategy is to increase its share of branded products in CIS markets. Vivimed shall be launching these products this year. Our purpose is to offer innovative and top quality formulations at affordable prices,” Ramesh Krishnamurthy, CEO, Vivimed Labs said.

PTI

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.

Tags

Related Articles

Leave a Reply

Back to top button
Close
Close